ES543938A0 - Un procedimiento para preparar un gen fusionado que codifica una proteina hibrida susceptible de marcado y empleo en diagnosis. - Google Patents
Un procedimiento para preparar un gen fusionado que codifica una proteina hibrida susceptible de marcado y empleo en diagnosis.Info
- Publication number
- ES543938A0 ES543938A0 ES543938A ES543938A ES543938A0 ES 543938 A0 ES543938 A0 ES 543938A0 ES 543938 A ES543938 A ES 543938A ES 543938 A ES543938 A ES 543938A ES 543938 A0 ES543938 A0 ES 543938A0
- Authority
- ES
- Spain
- Prior art keywords
- hybrid protein
- fused gene
- marking
- diagnosis
- codes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/25—Shigella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/55—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Botany (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61819984A | 1984-06-07 | 1984-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8708014A1 ES8708014A1 (es) | 1987-09-01 |
ES543938A0 true ES543938A0 (es) | 1987-09-01 |
Family
ID=24476731
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES543938A Expired ES8708014A1 (es) | 1984-06-07 | 1985-06-05 | Un procedimiento para preparar un gen fusionado que codifica una proteina hibrida susceptible de marcado y empleo en diagnosis. |
ES557103A Expired ES8801376A1 (es) | 1984-06-07 | 1986-10-01 | Un procedimiento para preparar una proteina hibrida |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES557103A Expired ES8801376A1 (es) | 1984-06-07 | 1986-10-01 | Un procedimiento para preparar una proteina hibrida |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0185076B1 (es) |
JP (2) | JP2510984B2 (es) |
AT (1) | ATE79136T1 (es) |
AU (1) | AU592310B2 (es) |
CA (1) | CA1339359C (es) |
DE (1) | DE3586456T2 (es) |
ES (2) | ES8708014A1 (es) |
FI (1) | FI100253B (es) |
NO (1) | NO176807C (es) |
NZ (1) | NZ212312A (es) |
WO (1) | WO1986000090A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU570762B2 (en) * | 1983-12-23 | 1988-03-24 | Australian National University, The | Cloning of cdna for il-3 |
US5668255A (en) * | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
AU577856B2 (en) * | 1985-01-17 | 1988-10-06 | Immunex Corporation | Cloning and characterization of the human interleukin 1 gene |
US4892827A (en) * | 1986-09-24 | 1990-01-09 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
ATE243754T1 (de) * | 1987-05-21 | 2003-07-15 | Micromet Ag | Multifunktionelle proteine mit vorbestimmter zielsetzung |
US5091513A (en) * | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
US5132405A (en) * | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
US5258498A (en) * | 1987-05-21 | 1993-11-02 | Creative Biomolecules, Inc. | Polypeptide linkers for production of biosynthetic proteins |
US5095096A (en) * | 1987-05-29 | 1992-03-10 | Sagami Chemical Research Center | Fused protein comprising lymphotoxin |
JP2878341B2 (ja) * | 1989-03-03 | 1999-04-05 | 学校法人藤田学園 | 人工機能性ポリペプチド |
WO1990012877A1 (en) * | 1989-04-19 | 1990-11-01 | Cetus Corporation | Multifunctional m-csf proteins and genes encoding therefor |
AU657087B2 (en) * | 1989-12-22 | 1995-03-02 | Seragen Incorporated | Hybrid molecules having translocation region and cell-binding region |
JP3311346B2 (ja) * | 1990-03-02 | 2002-08-05 | ボストン・メディカル・センター・コーポレーション | 改良されたキメラ毒素 |
US5837491A (en) * | 1991-11-04 | 1998-11-17 | Xoma Corporation | Polynucleotides encoding gelonin sequences |
US6146850A (en) * | 1991-11-04 | 2000-11-14 | Xoma Corporation | Proteins encoding gelonin sequences |
US5621083A (en) * | 1991-11-04 | 1997-04-15 | Xoma Corporation | Immunotoxins comprising ribosome-inactivating proteins |
WO1994025616A1 (en) * | 1993-04-28 | 1994-11-10 | Worcester Foundation For Experimental Biology | Cell-targeted lytic pore-forming agents |
US5777078A (en) * | 1993-04-28 | 1998-07-07 | Worcester Foundation For Experimental Biology | Triggered pore-forming agents |
US6635740B1 (en) | 1997-03-27 | 2003-10-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Ligand/lytic peptide compositions and methods of use |
WO1999005167A1 (en) | 1997-07-25 | 1999-02-04 | University Of Massachusetts | Designed protein pores as components for biosensors |
US6680058B1 (en) | 1997-09-03 | 2004-01-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Compositions and methods for contraception in or sterilization of mammals |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE25197T1 (de) * | 1982-05-12 | 1987-02-15 | Harvard College | Hybridproteinekodierende fusionierte gene, sie enthaltende klonierungsvektoren und deren verwendung. |
US4468382A (en) * | 1982-07-15 | 1984-08-28 | New England Medical Center, Inc. | Polypeptide-toxin hybrid protein |
-
1985
- 1985-06-05 ES ES543938A patent/ES8708014A1/es not_active Expired
- 1985-06-05 NZ NZ212312A patent/NZ212312A/xx unknown
- 1985-06-07 DE DE8585903136T patent/DE3586456T2/de not_active Expired - Fee Related
- 1985-06-07 JP JP60502723A patent/JP2510984B2/ja not_active Expired - Lifetime
- 1985-06-07 EP EP85903136A patent/EP0185076B1/en not_active Expired - Lifetime
- 1985-06-07 AU AU44916/85A patent/AU592310B2/en not_active Ceased
- 1985-06-07 CA CA000483407A patent/CA1339359C/en not_active Expired - Fee Related
- 1985-06-07 AT AT85903136T patent/ATE79136T1/de not_active IP Right Cessation
- 1985-06-07 WO PCT/US1985/001081 patent/WO1986000090A1/en active IP Right Grant
-
1986
- 1986-02-06 NO NO860421A patent/NO176807C/no not_active IP Right Cessation
- 1986-02-06 FI FI860541A patent/FI100253B/fi active IP Right Grant
- 1986-10-01 ES ES557103A patent/ES8801376A1/es not_active Expired
-
1993
- 1993-12-01 JP JP5302099A patent/JPH06205684A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES557103A0 (es) | 1987-12-16 |
WO1986000090A1 (en) | 1986-01-03 |
EP0185076A4 (es) | 1987-11-09 |
AU592310B2 (en) | 1990-01-11 |
JPH06205684A (ja) | 1994-07-26 |
NO176807C (no) | 1995-05-31 |
FI860541A0 (fi) | 1986-02-06 |
FI860541A (fi) | 1986-02-06 |
NO176807B (no) | 1995-02-20 |
ES8801376A1 (es) | 1987-12-16 |
FI100253B (fi) | 1997-10-31 |
CA1339359C (en) | 1997-08-26 |
ES8708014A1 (es) | 1987-09-01 |
ATE79136T1 (de) | 1992-08-15 |
DE3586456D1 (de) | 1992-09-10 |
NO860421L (no) | 1986-02-06 |
JP2510984B2 (ja) | 1996-06-26 |
JPS61502304A (ja) | 1986-10-16 |
NZ212312A (en) | 1988-09-29 |
AU4491685A (en) | 1986-01-10 |
EP0185076B1 (en) | 1992-08-05 |
EP0185076A1 (es) | 1986-06-25 |
DE3586456T2 (de) | 1993-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES543938A0 (es) | Un procedimiento para preparar un gen fusionado que codifica una proteina hibrida susceptible de marcado y empleo en diagnosis. | |
ES522315A0 (es) | Un procedimiento para obtener una proteina hibrida. | |
ATE544776T1 (de) | Chimäre dna-bindeproteine | |
GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
ES540029A0 (es) | Procedimiento para preparar aldehidos peptidos conteniendo prolina con actividad farmaceutica. | |
EA199800946A1 (ru) | Концентрированный препарат антител | |
NO863596D0 (no) | Enbakteriell metionin n-terminal peptidase. | |
DE69228701D1 (de) | Fragmente von Prion Proteinen. | |
ES552534A0 (es) | Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original. | |
DE69434384D1 (de) | Metalkomplexbildner | |
DE69132902D1 (de) | Methoden zur identifizierung heterofunktionaler fusionsproteine | |
FI970979A (fi) | Muokatut ihmisen C3-proteiinit | |
AR010139A1 (es) | Una molecula que tiene una region de union de antigeno especifica para un epitope del antigeno fas, un anticuerpo, adn que codifica cualquier porcionindividual del polipeptido de dicha molecula, un vector de adn recombiante, una celula huesped, e coli, el uso de una molecula para la preparacion de u | |
NO922421L (no) | Collagenbindende protein, samt fremstilling derav | |
NO862920L (no) | Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse. | |
NO169819C (no) | Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne | |
DK0815141T3 (da) | Antistof mod et fusionspolypeptid omfattende en histidinandel | |
NO854903L (no) | Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse. | |
DE68917520T2 (de) | Verfahren und Systeme zur Herstellung von HIV-Antigenen. | |
DE3886032D1 (de) | Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren. | |
IT8224734A0 (it) | Morsetto per effettuare collegamenti elettrici, in particolare in costruzioni civili, e procedimento per l'esecuzione ditali collegamenti. | |
DK381787A (da) | Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse | |
ATE17190T1 (de) | Mittel zur tumorlokalisierung und therapie mit markierten antikoerpern und antikoerperfragmenten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20040624 |